ASSEMBLY FINANCIAL INSTITUTIONS AND INSURANCE COMMITTEE

STATEMENT TO

ASSEMBLY, No. 4015

with committee amendments

STATE OF NEW JERSEY

DATED:  MAY 15, 2025

      The Assembly Financial Institutions and Insurance Committee reports favorably and with committee amendments Assembly Bill No. 4015.

      This bill requires pharmacies to provide certain information regarding insulin manufacturer assistance programs.

      As amended, the bill requires a pharmacy practice site to display, in a conspicuous manner, a notice on its website concerning insulin manufacturer assistance programs, to be created by the Department of Health.  A pharmacy practice site is also required to provide, at the request of an individual, a pamphlet created by the department concerning the insulin manufacturer assistance programs to any individual purchasing a prescription for insulin, or to any individual requesting a pamphlet.  Insulin manufacturers offering an assistance program may inform the department of their intention to be included in the notices and pamphlets.  The bill is to take effect twelve months from the date it is signed into law.

      As amended and reported by the committee, Assembly Bill No. 4015 is identical to Senate Bill No. 2886 (1R), which was reported by the committee on this same date.

COMMITTEE AMENDMENTS:

      The committee amended the bill to:

      (1)  require a pharmacy to display, in a conspicuous manner, information about insulin assistance programs on the website of the pharmacy and have the Department of Health draft the information to include on the website;

      (2)  make the distribution of pamphlets on insulin assistance programs by request of an individual to the pharmacy; and

      (3)  alter the effective date to twelve months from the date it is signed.